The Joint ECOG-ACRIN Program supports cancer researchers expanding innovative phase II trials into community care settings, with the goal of reducing cancer’s burden and improving adults’ quality of life and survival.
Funder: Gateway for Cancer Research
Due Dates: November 6, 2026 (tentative LOI deadline) | Full application deadline specified in invitation
Funding Amounts:
Summary: Supports the expansion of innovative phase II cancer trials into community settings through a partnership with ECOG-ACRIN.
Key Information: The full grant application deadline is provided only to invited applicants.
Gateway for Cancer Research runs this joint program with the Eastern Cooperative Oncology Group–American College of Radiology Imaging Network (ECOG-ACRIN) Cancer Research Group. It supports the expansion of innovative phase II cancer trials into community settings through ECOG-ACRIN’s network of nearly 1,400 academic and community-based cancer centers and hospitals.
The partnership connects Gateway’s support for cancer research with sites where patients receive care in their communities. Its aim reflects ECOG-ACRIN’s mission to reduce the burden of cancer and improve quality of life and survival for adults with cancer.